Provectus Pharmaceuticals INC
SEC CIK 315545 · PVCT · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Rodrigues Dominic | Director · President | filed 2017 - 2026 |
| Lacy John III | Director | filed 2018 - 2026 |
| Bailey Webster | Director | filed 2020 - 2026 |
| Pershing Edward | Director · CEO | filed 2018 - 2026 |
| Wachter Eric PHD | Director · Vice President Pharmaceuticals | filed 2006 - 2024 |
| Horowitz Bruce | Director · Chief Operating Officer | filed 2017 - 2021 |
| Koe Jan | Director | filed 2012 - 2016 |
| Scott Timothy PHD | Director · President | filed 2006 - 2015 |
| Dees H Craig | Director · Chief Executive Officer | filed 2006 - 2015 |
| Mcmasters Kelly M | Director | filed 2008 - 2015 |
| Smith Alfred E. IV | Director | filed 2011 - 2015 |
| Fuchs Stuart | Director | filed 2006 - 2011 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Raines Heather | Chief Financial Officer | filed 2019 - 2024 |
| Glass John R | See Remarks | filed 2016 - 2017 |
| Culpepper Peter R | Interim CEO, CFO, COO | filed 2006 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.